This statistic shows the results of a survey conducted in the United States in February 2017, by gender. U.S. adults were given a list of 11 options and asked to select which consequences they would expect if U.S. pharma companies were forced to move their manufacturing from abroad back to the U.S. About 42 percent of female respondents said that they would expect higher drug prices, while 41 percent of male respondents indicated the same.
Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender
Characteristic
Female
Male
Higher drug prices
42%
41%
Lower drug prices
18%
18%
Better quality of drugs
21%
23%
Better quality control
31%
33%
Fairer labor conditions
20%
19%
More jobs for US citizens
48%
44%
Decrease in manufacturing companies
9%
12%
Smaller range of available drugs
14%
15%
Other
1%
0%
Don't know
14%
13%
None of the above
4%
3%
0%5%10%15%20%25%30%35%40%45%50%55%
Add this content to your personal favorites. These can be accessed from the favorites menu in the main navigation.
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Original question: "A lot of US pharma companies manufacture abroad. Which consequences do you expect in case pharma companies were forced to manufacture in the US?" (multiple pick)
Learn more about how Statista can support your business.
Statista Survey. (February 10, 2017). Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender [Graph]. In Statista. Retrieved May 14, 2025, from https://www.statista.com/statistics/695767/potential-consequences-of-moving-us-pharma-manufacturing-by-gender/
Statista Survey. "Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender." Chart. February 10, 2017. Statista. Accessed May 14, 2025. https://www.statista.com/statistics/695767/potential-consequences-of-moving-us-pharma-manufacturing-by-gender/
Statista Survey. (2017). Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender. Statista. Statista Inc.. Accessed: May 14, 2025. https://www.statista.com/statistics/695767/potential-consequences-of-moving-us-pharma-manufacturing-by-gender/
Statista Survey. "Opinions on Consequences in Case U.S. Pharma Companies Would Be Forced to Manufacture In-country as of 2017, by Gender." Statista, Statista Inc., 10 Feb 2017, https://www.statista.com/statistics/695767/potential-consequences-of-moving-us-pharma-manufacturing-by-gender/
Statista Survey, Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender Statista, https://www.statista.com/statistics/695767/potential-consequences-of-moving-us-pharma-manufacturing-by-gender/ (last visited May 14, 2025)
Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender [Graph], Statista Survey, February 10, 2017. [Online]. Available: https://www.statista.com/statistics/695767/potential-consequences-of-moving-us-pharma-manufacturing-by-gender/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
